- Filed
- Oct 15, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Oct 13, 2021 | 680.27M sh |
| Cash And Equivalents | Q3 2021 · Aug 31, 2021 | $294.73K |
| Cash And Equivalents | Q3 2021 · Nov 30, 2020 | $200.86K |
| Current Liabilities | Q3 2021 · Aug 31, 2021 | $4.18M |
| Current Liabilities | Q3 2021 · Nov 30, 2020 | $4.76M |
| Total Liabilities | Q3 2021 · Aug 31, 2021 | $4.51M |
| Total Liabilities | Q3 2021 · Nov 30, 2020 | $5.02M |
| Current Assets | Q3 2021 · Aug 31, 2021 | $578.67K |
| Current Assets | Q3 2021 · Nov 30, 2020 | $516.46K |
| Total Assets | Q3 2021 · Aug 31, 2021 | $1.38M |
| Total Assets | Q3 2021 · Nov 30, 2020 | $1.18M |
| Shares Diluted | Q3 2021 · Aug 31, 2020 | 251.17M sh |
| Shares Diluted | Q3 2021 · Aug 31, 2020 | 28.1M sh |
| Capex | Q3 2021 · Aug 31, 2020 | $89.24K |
| Operating Cash Flow | Q3 2021 · Aug 31, 2020 | $31.85K |
| Stockholders Equity | Q3 2021 · Aug 31, 2020 | −$4.31M |
| Stockholders Equity | Q3 2021 · May 31, 2020 | −$5.32M |
| Stockholders Equity | Q3 2021 · Nov 30, 2019 | −$3.52M |
| Eps Diluted | Q3 2021 · Aug 31, 2020 | $0.00 |
| Eps Diluted | Q3 2021 · Aug 31, 2020 | −$0.03 |
| Eps Basic | Q3 2021 · Aug 31, 2020 | $0.03 |
| Eps Basic | Q3 2021 · Aug 31, 2020 | −$0.03 |
| Sga Expense | Q3 2021 · Aug 31, 2020 | $267.46K |
| Sga Expense | Q3 2021 · Aug 31, 2020 | $750.77K |
| Net Income restated | Q3 2021 · Aug 31, 2020 | $1.15M |
| Net Income restated | Q3 2021 · Aug 31, 2020 | −$280.43K |
| Operating Income | Q3 2021 · Aug 31, 2020 | −$83.31K |
| Operating Income | Q3 2021 · Aug 31, 2020 | −$245.21K |
| Gross Profit | Q3 2021 · Aug 31, 2020 | $184.14K |
| Gross Profit | Q3 2021 · Aug 31, 2020 | $505.57K |
| Revenue | Q3 2021 · Aug 31, 2020 | $800.68K |
| Revenue | Q3 2021 · Aug 31, 2020 | $2.89M |